A single centre, proof-of-concept clinical study for SM-88 in advanced metastatic cancer patients
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2017
At a glance
- Drugs SM 88 (Primary)
- Indications Advanced breast cancer; Cancer
- Focus First in man; Proof of concept; Therapeutic Use
- Sponsors Tyme Technologies
- 06 Nov 2017 Results from women with metastatic breast cancer (n = 14) presented in a Tyme Technologies media release.
- 19 Oct 2017 Results published in a Tyme Technologies media release.
- 07 Sep 2017 Long-term updated results published in a Tyme Technologies Media Release.